zidovudine has been researched along with Muscular Weakness in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barchiesi, F; Cirioni, O; Fragola, V; Gabrielli, E; Giacometti, A; Marchionni, E; Massella, M; Weimer, LE | 1 |
| Feinstein, R; Godfrey, E; Morgello, S; Simpson, DM; Tagliati, M; Wolfe, D | 1 |
2 other study(ies) available for zidovudine and Muscular Weakness
| Article | Year |
|---|---|
Sustained increase of serum creatine phosphokinase levels and progressive muscle abnormalities associated with raltegravir use during 32-week follow-up in an HIV-1 experienced patient on simplified HAART regimen, intolerant to protease inhibitors and abac
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Creatine Kinase; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Muscle Weakness; Myalgia; Pyrrolidinones; Raltegravir Potassium; Zidovudine | 2013 |
Mitochondrial abnormalities in human immunodeficiency virus-associated myopathy.
Topics: Adult; Antiviral Agents; Creatine Kinase; Female; HIV Infections; Humans; Male; Microscopy, Electron; Middle Aged; Mitochondria, Muscle; Muscle Fibers, Skeletal; Muscle Weakness; Muscles; Muscular Diseases; Pain; Zidovudine | 1995 |